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Background:  Most studies have confirmed the beneficial effects of the autologous bone marrow mononuclear cell (BMMC) transplantation 
on angina, myocardial perfusion, regional wall motion, and LV ejection fraction (LVEF). However, it is still unclear if cell transplantation can affect 
ventricular dyssynchrony. The aim of this study was to evaluate additional benefit from combination of BMMC transplantation with endocardial CRT 
system implantation in patients with severe heart failure (HF) and ventricular dyssynchrony.
Methods:  Twenty six patients with HF and dyssynchrony underwent intramyocardial transplantation of the BMMC and endocardial cardiac 
resynchronization therapy (CRT) system implantation. This randomised, single-blind, cross-over study compared clinical and echocardiographic 
parameters during two periods: 6 months of active CRT (BMMC+CRTact group) and 6 months of inactive CRT (BMMC+CRTinact group) pacing.
Results:  In the BMMC+CRTact group more patients significantly improved NYHA classes (p<0.001), 6-minutes walk test (p<0.001) and quality of 
life (p=0.004) compared with the BMMC+CRTinact group. Both groups improved myocardial perfusion by SPECT. The summed rest and stress score 
decreased significantly within 12 months in the BMMC+CRTact and BMMC+CRTinact groups compared to baseline. The CRT as contrasted with 
cell injection did not influence the myocardial perfusion pattern, on the contrary cell injection did not influence on the ventricular dyssynchrony. 
Echocardiography revealed an improved significantly LVEF (p<0.001), reduced LV end-systolic volume (p=0.03), and improved LV synchrony in the 
BMMC+CRTact group compared to the BMMC+CRTinact group.
Conclusions: Combining CRT procedure and intramyocardial bone marrow cell injection allows to considerably reduce ventricular dyssynchrony 
and, as a result, significantly improve LV function and the outcome of patients with severe HF and ventricular dyssynchrony.
